Discussion on the Focus of On-site Inspection of Clinical Trials of Lung Cancer 
Targeted Therapy and Immunotherapy Drugs

As lung cancer targeted therapy and immunotherapy drugs are the current hot spot in the research and development area of new anti-tumor drugs, the amount of clinical trial in this area is increasing year by year. On the basis of combing the on-site inspections of drug registration clinical trials from 2019 to 2021, combined with the characteristics of lung cancer targeted therapy and immunotherapy drugs, this paper discusses the focus of on-site inspection of clinical trials of such drugs, and puts forward suggestions for the compliant implementation of lung cancer clinical trials. 
 DOI: 10.3779/j.issn.1009-3419.2022.101.32
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research